In our research for our annual Community Oncology Trend Report, we survey independent community oncology practices’ perceived likelihood of joining an oncology network aggregator (eg, the US Oncology Network, OneOncology, American Oncology Network) in the next 5 years.
Survey data collected from 2021 to 2023 show that, year-over-year, independent practices rated increasingly higher likelihoods of joining a network aggregator, and the percentage of practices indicating a high likelihood of joining a network aggregator rose from 18% in 2021 to 35% in 2023 (Figure 1).
An increasingly consolidated provider market, competitive and economic advantages touted by network aggregators, and mixed perspectives on these promised benefits color the story behind whether practices want to join these network aggregators.
For more valuable insights, read our recently released 2023 Community Oncology Annual Trend Report. For further insights and musings on the oncology sector, check out our latest articles at https://www.hmpmarketaccessinsights.com/insights.
As always, please feel free to reach out with any questions or comments you may have.
Not only does Emma have over a decade of experience supporting academic health systems and integrated delivery networks (IDNs), but she’s also the go-to for a delicious apple pie.
Emma BijesseOur team looked back on some of the most thought-provoking insights from conversations with key decision-makers in oncology. In this podcast episode, we explore the challenges and opportunities faced by oncologists, payers, and pathway developers.
Ashutosh ShethEasier access to oncology pathway recommendations encourages oncologists’ usage and considerations of these recommendations. Our new 2024-2025 Oncology Clinical Pathways Impact Report reveals the variability in pathway integration and usage.
Cindy Chen